Bioactivity of betulinic acid nanoemulsions on skin carcinogenesis in transgenic mice K14E6




Betulinic acid, Medium chain fatty acids, Mice, Modified lecithin, Nanoemulsion, Skin tumors


Alternative therapies for cancer treatment have been developed using bioactive compounds such as betulinic acid (BA). The objective of this study was to investigate the bioactivity of BA in its free form and compare it with its nano-encapsulated form under a skin carcinogenesis protocol in a genetically modified murine model. K14E6 and FVB mice were divided into four groups to be treated with free BA and with betulinic acid nanoemulsion (BANE). Lecithin enriched with medium chain fatty acids (MCFAs) was employed as an emulsifier to prepare the nanoemulsions with a mean droplet size of 40 nm. Skin tumors were induced by exposure to DMBA and TPA directly to the transgenic mice. Tumor development was completely inhibited by BANE and by 70% with free BA. This was validated by histological sections and the gene expression of the Cdk4 and Casp8 genes.


Download data is not yet available.


Aisha AFA, Abu-Salah KM, Ismail Z, Malik A, Abdul S. 2012. α-Mangostin Enhances Betulinic Acid Cytotoxicity and Inhibits Cisplatin Cytotoxicity on HCT 116 Colorectal Carcinoma Cells. Molecules 17, 2939-2954.

Ali-Seyed M, Jantan I, Vijayaraghavan K, Bukhari SNA. 2016. Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy. Chem. Biol. Drug Des. 87, 517-536.

Bishayee A, Block K. 2015. A broad-spectrum integrative design for cancer prevention and therapy: The challenge ahead. Semin. Cancer Biol. 35, S1-S4.

Chen CL, Chen CY, Chen YP, Huang YB, Lin MW, Wu DC, Huang HT, Liu MY, Chang HW, Kao YC, Yang PH. 2016. Betulinic acid enhances TGF-ß signaling by altering TGF-ß receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells. J. Biomed. Sci. 23, 1-15.

Cavazos-Garduño A, Ochoa Flores AA, Serrano-Niño JC, Martínez-Sanchez CE, Beristain CI, García HS. 2015. Preparation of betulinic acid nanoemulsions stabilized by ω-3 enriched phosphatidylcholine. Ultrason. Sonochem. 24, 204-213.

Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S. 2011. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11, 371.

Ciurlea SA, Dehelean CA, Ionescu D, Berko S, Csanyi E, Hadaruga DI, Ganta S, Amiji MM. 2010. A comparative study regarding melanoma activity of Betulinic acid on topical ointment vs. systemic nanoemulsion delivery systems. J. Agroaliment. Processes Technol. 16, 420-426.

Das J, Samadder A, Das S, Paul A, Rahman A, Khuda-Bukhsh AR. 2016. Nanopharmaceutical Approach for Enhanced Anti-Cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target: -Anti-Cancer Potential of Nano-betulinic acid in Lung Cancer. J. Pharmacopunct. 19, 37-44.

Dehelean CA, Feflea S, Ganta S, Amiji M. 2011. Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay. J. Biomed. Nanotechnol. 7, 317-24.

Diaz-Cano SJ. 2015. Pathological bases for a robust application of cancer molecular classification. Int. J. Mol. Sci. 16, 8655-8675.

Fulda S. 2009. Betulinic acid: A natural product with anticancer activity. Mol. Nutr. Food Res. 53, 140-146.

Fulda S, Kroemer G. 2009. Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov. Today 14, 885-890.

Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, Darwiche N. 2015. Cell death mechanisms of plant-derived anticancer drugs: Beyond apoptosis. Apoptosis. 20, 1531-1562.

Harwansh RK, Mukherjee PK, Biswas S. 2017. Nanoemulsion as a novel carrier system for improvement of betulinic acid oral bioavailability and hepatoprotective activity. J. Mol. Liq. 237, 361-371.

Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. 2012. Nanotechnology-based approaches in anticancer research. Int. J. Nanomedicine 7, 4391-4408.

Kabri TH, Arab-Tehrany E, Belhaj N, Linder M. 2011. Physico-chemical characterization of nano-emulsions in cosmetic matrix enriched on omega-3. J. Nanobiotechnology 9, 41.

Li X, Chen JF, Yang B, Li DM, Wang YH, Wang WF. 2014. Production of structured phosphatidylcholine with high content of DHA/EPA by immobilized phospholipase A1-catalyzed transesterification. Int. J. Mol. Sci. 15, 15244-15258.

Mendoza-Villanueva D, Diaz-Chavez J, Uribe-Figueroa L, Rangel-Escareão C, Hidalgo-Miranda A, March-Mifsut S, Jimenez-Sanchez G, Lambert P, Garglio P. 2008. Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice. BMC Cancer 8, 347.

Ochoa-Flores AA, Hernandez-Becerra JA, Cavazos-Garduño A, Soto-Rodriguez I, Sanchez-Otero MG, Vernon-Carter EJ, Garcia HS. 2017. Enhanced Bioavailability of Curcumin Nanoemulsions Stabilized with Phosphatidylcholine Modified with Medium Chain Fatty Acids. Curr. Drug Deliv. 14, 377-385.

Palumbo MO, Kavan P, Miller WH, Panasci L, Assouline S, Johnson N, Cohen V, Patenaude F, Pollak M, Jagoe RT, Batist G. 2013. Systemic cancer therapy: Achievements and challenges that lie ahead. Front. Pharmacol. 4 MAY, 1-9.

Pejin B, Jovanovic K, Mojovic M, Savic A. 2013. New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012. Curr. Top. Med. Chem. 13 (21), 2745-2766.

Pejin B, Kojic V, Bogdanovic G. 2014. An insight into the cytotoxic activity of phytol at in vitro conditions. Nat. Prod. Res. 28 (22), 2053-2056.

Rieber M, Rieber MS. 2006. Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status. Int. J. Cancer 118, 1135-1143.

Rodríguez VM, Shuk E, Arniella G, González CJ, Gany F, Hamilton JG, Gold GS, Hay JL. 2018. A qualitative exploration of Latinos’ perceptions about skin cancer : The role of gender and linguistic acculturation. J. Cancer Educ. 32, 438-446.

Salvia-Trujillo L, Qian C, Martín-Belloso O, McClements DJ. 2013. Influence of particle size on lipid digestion and b-carotene bioaccessibility in emulsions and nanoemulsions. Food Chem. 141, 1475-1480.

Saneja A, Arora D, Kumar R, Dubey RD, Panda AK, Gupta PN. 2018. Therapeutic applications of betulinic acid nanoformulations. Ann. N.Y. Acad. Sci. 1421, 1-14.

Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, Mondhe DM, Panda AK, Gupta PN. 2017. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int. J. Pharm. 531, 153-166.

Soica C, Danciu C, Savoiu-Balint G, Borcan F, Ambrus R, Zupko I, Bojin F, Coricovac D, Ciurlea S, Avram S, Dehelean CA, Olariu T, Matusz P. 2014. Betulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells. Int. J. Mol. Sci. 15, 8235-8255.

Thurnher D, Turhani D, Pelzmann M, Wannemacher B, Knerer B, Formanek M, Wacheck V, Selzer E. 2003. Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells. Head Neck. 25, 732-740.

Vikbjerg AF, Rusig JY, Jonsson G, Mu H, Xu X. 2006. Strategies for lipase-catalyzed production and the purification of structured phospholipids. Eur. J. Lipid Sci. Technol. 108, 802-811.

Xu T, Pang Q, Wang Y, Yan X. 2017. Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells. Int. J. Mol. Med. 40, 1669-1678.

Yang LJ, Chen Y, Ma Q, Fang J, He J, Cheng YQ, Wu QK. 2010. Effect of betulinic acid on the regulation of Hiwi and cyclin B1 in human gastric adenocarcinoma AGS cells. Acta Pharmacol. Sin. 31, 66-72.



How to Cite

Agame-Lagunes B, Alegria-Rivadeneyra M, Alexander-Aguilera A, Quintana-Castro R, Torres-Palacios C, Grube-Pagola P, Cano-Sarmiento C, García-Varela R, García H. Bioactivity of betulinic acid nanoemulsions on skin carcinogenesis in transgenic mice K14E6. grasasaceites [Internet]. 2022Jan.12 [cited 2022Jan.19];72(4):e433. Available from:




Funding data